Human Rotavirus Vaccine Market Report – Research, Industry Analysis Reports and Market Demands

Global Human Rotavirus Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Human Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
- 1.2.1 Rotarix
- 1.2.2 RotaTeq
- 1.2.3 Rotavac
- 1.2.4 Rotavin-M1
- 1.2.5 Lanzhou lamb
1.3 Market Analysis by Applications
- 1.3.1 Hospitals
- 1.3.2 Clinics
- 1.3.3 Academic and Research
- 1.3.4 Others
1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
  - 1.4.1.1 United States Market States and Outlook (2014-2024)
  - 1.4.1.2 Canada Market States and Outlook (2014-2024)
  - 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  - 1.4.2.1 Germany Market States and Outlook (2014-2024)
  - 1.4.2.2 France Market States and Outlook (2014-2024)
  - 1.4.2.3 UK Market States and Outlook (2014-2024)
  - 1.4.2.4 Russia Market States and Outlook (2014-2024)
  - 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  - 1.4.3.1 China Market States and Outlook (2014-2024)
  - 1.4.3.2 Japan Market States and Outlook (2014-2024)
  - 1.4.3.3 Korea Market States and Outlook (2014-2024)
  - 1.4.3.4 India Market States and Outlook (2014-2024)
  - 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
  - 1.4.4.1 Brazil Market States and Outlook (2014-2024)
  - 1.4.4.2 Egypt Market States and Outlook (2014-2024)
  - 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
  - 1.4.4.4 South Africa Market States and Outlook (2014-2024)
  - 1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Merck & Co., Inc.
- 2.1.1 Business Overview
- 2.1.2 Human Rotavirus Vaccine Type and Applications
  - 2.1.2.1 Product A
  - 2.1.2.2 Product B
- 2.1.3 Merck & Co., Inc. Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bharat Biotech
- 2.2.1 Business Overview
- 2.2.2 Human Rotavirus Vaccine Type and Applications
  - 2.2.2.1 Product A
  - 2.2.2.2 Product B
- 2.2.3 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline plc.
- 2.3.1 Business Overview
- 2.3.2 Human Rotavirus Vaccine Type and Applications
  - 2.3.2.1 Product A
  - 2.3.2.2 Product B
- 2.3.3 GlaxoSmithKline plc. Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Human Rotavirus Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Human Rotavirus Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Human Rotavirus Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
- 3.3.1 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2018
- 3.3.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend

4 Global Human Rotavirus Vaccine Market Analysis by Regions

4.1 Global Human Rotavirus Vaccine Sales, Revenue and Market Share by Regions
- 4.1.1 Global Human Rotavirus Vaccine Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Human Rotavirus Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)

5 North America Human Rotavirus Vaccine by Country

5.1 North America Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
- 5.1.1 North America Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)

6 Europe Human Rotavirus Vaccine by Country

6.1 Europe Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
- 6.1.1 Europe Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.4 France Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)

7 Asia-Pacific Human Rotavirus Vaccine by Country

7.1 Asia-Pacific Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.5 India Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)

8 South America Human Rotavirus Vaccine by Country

8.1 South America Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
- 8.1.1 South America Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)

9 Middle East and Africa Human Rotavirus Vaccine by Countries

9.1 Middle East and Africa Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)

10 Global Human Rotavirus Vaccine Market Segment by Type

10.1 Global Human Rotavirus Vaccine Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Human Rotavirus Vaccine Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Human Rotavirus Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Rotarix Sales Growth and Price
- 10.2.1 Global Rotarix Sales Growth (2014-2019)
- 10.2.2 Global Rotarix Price (2014-2019)
10.3 RotaTeq Sales Growth and Price
- 10.3.1 Global RotaTeq Sales Growth (2014-2019)
- 10.3.2 Global RotaTeq Price (2014-2019)
10.4 Rotavac Sales Growth and Price
- 10.4.1 Global Rotavac Sales Growth (2014-2019)
- 10.4.2 Global Rotavac Price (2014-2019)
10.5 Rotavin-M1 Sales Growth and Price
- 10.5.1 Global Rotavin-M1 Sales Growth (2014-2019)
- 10.5.2 Global Rotavin-M1 Price (2014-2019)
10.6 Lanzhou lamb Sales Growth and Price
- 10.6.1 Global Lanzhou lamb Sales Growth (2014-2019)
- 10.6.2 Global Lanzhou lamb Price (2014-2019)

11 Global Human Rotavirus Vaccine Market Segment by Application

11.1 Global Human Rotavirus Vaccine Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Academic and Research Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)

12 Human Rotavirus Vaccine Market Forecast (2019-2024)

12.1 Global Human Rotavirus Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Human Rotavirus Vaccine Market Forecast by Regions (2019-2024)
- 12.2.1 North America Human Rotavirus Vaccine Market Forecast (2019-2024)
- 12.2.2 Europe Human Rotavirus Vaccine Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Human Rotavirus Vaccine Market Forecast (2019-2024)
- 12.2.4 South America Human Rotavirus Vaccine Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Human Rotavirus Vaccine Market Forecast (2019-2024)
12.3 Human Rotavirus Vaccine Market Forecast by Type (2019-2024)
- 12.3.1 Global Human Rotavirus Vaccine Sales Forecast by Type (2019-2024)
- 12.3.2 Global Human Rotavirus Vaccine Market Share Forecast by Type (2019-2024)
12.4 Human Rotavirus Vaccine Market Forecast by Application (2019-2024)
- 12.4.1 Global Human Rotavirus Vaccine Sales Forecast by Application (2019-2024)
- 12.4.2 Global Human Rotavirus Vaccine Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

Description

Scope of the Report:
The worldwide market for Human Rotavirus Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Human Rotavirus Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Merck & Co., Inc.
Bharat Biotech
GlaxoSmithKline plc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb

Market Segment by Applications, can be divided into
Hospitals
Clinics
Academic and Research
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rotavirus Vaccine, with price, sales, revenue and global market share of Human Rotavirus Vaccine in 2017 and 2018.
Chapter 3, the Human Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Human Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.